Genelink Inc Overview
- Status
-
Public
- Employees
-
15

- Stock Symbol
-
GNLKQ

Genelink Inc General Information
Description
Genelink Inc is a genetics-based, personal healthcare firm that has developed DNA assessments measuring personal DNA tendencies. These small differences in DNA, called SNPs can indicate genetic variants, the protein products of which may not be performing at optimal levels and can be linked to aging and other wellness issues. The company's scientists use the DNA assessments information from each client to formulate products to optimize health and wellness within normal ranges. The company has a compilation of issued and pending patents that center on using DNA analysis for the purpose of customizing nutrition and skin care formulations for wellness and anti-aging.
Contact Information
- 8250 Exchange Drive
- Suite 120
- Orlando, FL 32809
- United States
Genelink Inc Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
174K |
Genelink Inc Financials Summary
In Thousands, USD |
TTM 30-Sep-2013 | FY 2012 31-Dec-2012 | FY 2011 31-Dec-2011 | FY 2010 31-Dec-2010 |
---|---|---|---|---|
EV | 2,835 | 2,400 | 12,889 | 5,329 |
Revenue | 1,579 | 2,136 | 4,685 | 7,840 |
EBITDA | (2,511) | (2,509) | (3,432) | (2,242) |
Net Income | (2,227) | (3,052) | (3,830) | (2,635) |
Total Assets | 1,284 | 1,455 | 2,780 | 1,721 |
Total Debt | 1,191 | 0 | 0 | 0 |
Genelink Inc Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Bernard Kasten MD | Chief Executive Officer & Chairman |
Genelink Inc Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000000 000000 00 | Genelink Inc | Chief Executive Officer & Chairman | 000 0000 |